Maplelane Capital’s QUESTCOR PHARMA INC QCOR Stock Holding History

Maplelane Capital’s Portfolio QCOR Stock Details QCOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1	Closed	–	–	219
2014 Q1	$0	Buy	+1	New	+$64	﹤0.01%	228

Other funds holding QCOR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maplelane Capital's QCOR Position: Q2 2014 in Review

Maplelane Capital sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 1 share.

Maplelane Capital first reported a position in QCOR in Q1 2014 and held it in 1 quarter. The position peaked at $0 in Q1 2014. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

Maplelane Capital reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
Maplelane Capital sold 1 QUESTCOR PHARMA INC share in Q2 2014.
Maplelane Capital first reported a position in QUESTCOR PHARMA INC in Q1 2014 and held it in 1 quarter.
Maplelane Capital's QUESTCOR PHARMA INC position peaked at $0 in Q1 2014.
320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Maplelane Capital's 13F filing for Q2 2014, filed 14 Aug 2014.